24,25-epoxycholesterol has been researched along with Astrocytoma, Grade IV in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullah, KG; Corley, CD; De Brabander, JK; Lim, SK; McBrayer, SK; McDonald, JG; Nguyen, TP; Nijhawan, D; Ortiz, F; Parada, LF; Sternisha, AC; Wang, HL; Wang, W; Wang, X; Williams, NS | 1 |
1 other study(ies) available for 24,25-epoxycholesterol and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Selective and brain-penetrant lanosterol synthase inhibitors target glioma stem-like cells by inducing 24(S),25-epoxycholesterol production.
Topics: Adult; Brain; Cholesterol; Glioblastoma; Glioma; Humans; Lanosterol | 2023 |